AAAAAA
Results: 226-250/766
Authors:
EDGAR AJ
LOSOWSKY MS
NOBLE JS
WICKRAMASINGHE SN
Citation: Aj. Edgar et al., IDENTIFICATION OF AN ARGININE(452) TO HISTIDINE SUBSTITUTION IN THE ERYTHROID 5-AMINOLEVULINATE SYNTHETASE GENE IN A LARGE PEDIGREE WITH X-LINKED HEREDITARY SIDEROBLASTIC ANEMIA, European journal of haematology, 58(1), 1997, pp. 1-4
Authors:
OSTERBORG A
WERNER A
HALAPI E
LUNDIN J
HARMENBERG U
WIGZELL H
MELLSTEDT H
Citation: A. Osterborg et al., CLONAL CD8(-) T-CELLS ARE INDUCED IN RESPONDING B-CELL LYMPHOMA PATIENTS TREATED WITH CAMPATH-1H (ANTI-CD52)() AND CD52(), European journal of haematology, 58(1), 1997, pp. 5-13
Authors:
RATIP S
PETROU M
OLD JM
WONKE B
PORTER JB
MONDELL B
Citation: S. Ratip et al., RELATIONSHIP BETWEEN THE SEVERITY OF BETA-THALASSEMIA SYNDROMES AND THE NUMBER OF ALLEVIATING MUTATIONS, European journal of haematology, 58(1), 1997, pp. 14-21
Authors:
BOURANTAS K
ECONOMOU G
GEORGIOU J
Citation: K. Bourantas et al., ADMINISTRATION OF HIGH-DOSES OF RECOMBINANT-HUMAN-ERYTHROPOIETIN TO PATIENTS WITH BETA-THALASSEMIA-INTERMEDIA - A PRELIMINARY TRIAL, European journal of haematology, 58(1), 1997, pp. 22-25
Authors:
HICSONMEZ G
GUMRUK F
ZAMANI PV
TUNCER MA
YETGIN S
GURGEY A
ATAHAN L
OZSOYLU S
Citation: G. Hicsonmez et al., HIGH-DOSE METHYLPREDNISOLONE FOR CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA AND UNFAVORABLE PRESENTING FEATURES, European journal of haematology, 58(1), 1997, pp. 26-31
Authors:
NEIRA M
RINCON J
ARIAS H
LAW SKA
PATARROYO M
Citation: M. Neira et al., ADHESION MOLECULE CD11A CD18-DEFICIENT BURKITTS-LYMPHOMA CELLS LACK THE TRANSCRIPT FOR THE BETA-INTEGRIN, BUT NOT THE ALPHA-INTEGRIN, SUBUNIT/, European journal of haematology, 58(1), 1997, pp. 32-39
Authors:
FABRIS F
CORDIANO I
SALVAN F
VALENTE M
LUZZATTO G
GIROLAMI A
Citation: F. Fabris et al., CHRONIC ISOLATED MACROTHROMBOCYTOPENIA WITH AUTOSOMAL-DOMINANT TRANSMISSION - A MORPHOLOGICAL AND QUALITATIVE PLATELET DISORDER, European journal of haematology, 58(1), 1997, pp. 40-45
Authors:
RONDELLI D
LAURIA F
ZINZANI PL
RASPADORI D
VENTURA MA
GALIENI P
BIRTOLO S
FORCONI F
ALGERI R
TURA S
Citation: D. Rondelli et al., 2-CHLORODEOXYADENOSINE IN THE TREATMENT OF RELAPSED REFRACTORY CHRONIC LYMPHOPROLIFERATIVE DISORDERS/, European journal of haematology, 58(1), 1997, pp. 46-50
Authors:
NOWAKGOTTL U
VIELHABER H
Citation: U. Nowakgottl et H. Vielhaber, ELEVATED LEVELS OF SOLUBLE THROMBOMODULIN IN PLASMA FROM CHILDREN WITH ARG-506 TO GLN MUTATION IN THE FACTORY V-GENE, European journal of haematology, 58(1), 1997, pp. 51-55
Authors:
CALAFAT J
JANSSEN H
KNOL EF
WELLER PF
EGESTEN A
Citation: J. Calafat et al., ULTRASTRUCTURAL-LOCALIZATION OF CHARCOT-LEYDEN CRYSTAL PROTEIN IN HUMAN EOSINOPHILS AND BASOPHILS, European journal of haematology, 58(1), 1997, pp. 56-66
Authors:
MIRABILE E
TESTA R
SAMPERI P
CONSALVO C
ROMANO V
SCHILIRO GG
Citation: E. Mirabile et al., A MILD FORM OF HB S-BETA-THALASSEMIA SYNDROME IS ASSURED IN SICILIAN PATIENTS BY BETA-I NT 6(T-]C)(MUTANT IVS), European journal of haematology, 58(1), 1997, pp. 67-69
Authors:
YOUNG N
KEISU M
Citation: N. Young et M. Keisu, DRUG-RELATED BLOOD DYSCRASIAS WORKSHOP - PREFACE, European journal of haematology, 57, 1996, pp. 5-5
Authors:
YOUNG NS
Citation: Ns. Young, INTRODUCTION, European journal of haematology, 57, 1996, pp. 6-8
Authors:
HEIMPEL H
Citation: H. Heimpel, WHEN SHOULD THE CLINICIAN SUSPECT A DRUG-INDUCED BLOOD DYSCRASIA, ANDHOW SHOULD HE PROCEED, European journal of haematology, 57, 1996, pp. 11-15
Authors:
BACIGALUPO A
Citation: A. Bacigalupo, ETIOLOGY OF SEVERE APLASTIC-ANEMIA AND OUTCOME AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION OR IMMUNOSUPPRESSION THERAPY, European journal of haematology, 57, 1996, pp. 16-19
Authors:
KAUFMAN DW
KELLY JP
JURGELON JM
ANDERSON T
ISSARAGRISIL S
WIHOLM BE
YOUNG NS
LEAVERTON P
LEVY M
SHAPIRO S
Citation: Dw. Kaufman et al., DRUGS IN THE ETIOLOGY OF AGRANULOCYTOSIS AND APLASTIC-ANEMIA, European journal of haematology, 57, 1996, pp. 23-30
Authors:
ISSARAGRISIL S
KAUFMAN DW
ANDERSON T
Citation: S. Issaragrisil et al., INCIDENCE AND NONDRUG ETIOLOGIES OF APLASTIC-ANEMIA IN THAILAND, European journal of haematology, 57, 1996, pp. 31-34
Authors:
MARY JY
GUIGUET M
BAUMELOU E
Citation: Jy. Mary et al., DRUG-USE AND APLASTIC-ANEMIA - THE FRENCH EXPERIENCE, European journal of haematology, 57, 1996, pp. 35-41
Authors:
WIHOLM BE
EMANUELSSON S
Citation: Be. Wiholm et S. Emanuelsson, DRUG-RELATED BLOOD DYSCRASIAS IN A SWEDISH REPORTING SYSTEM, 1985-1994, European journal of haematology, 57, 1996, pp. 42-46
Authors:
KELLY JP
JURGELON JM
ISSARAGRISIL S
KEISU M
KAUFMAN DW
Citation: Jp. Kelly et al., AN EPIDEMIOLOGIC-STUDY OF APLASTIC-ANEMIA - RELATIONSHIP OF DRUG EXPOSURES TO CLINICAL-FEATURES AND OUTCOME, European journal of haematology, 57, 1996, pp. 47-52
Authors:
YOUNG NS
Citation: Ns. Young, IMMUNE PATHOPHYSIOLOGY OF ACQUIRED APLASTIC-ANEMIA, European journal of haematology, 57, 1996, pp. 55-59
Authors:
SOCIE G
Citation: G. Socie, COULD APLASTIC-ANEMIA BE CONSIDERED A PRE-PRE-LEUKEMIC DISORDER, European journal of haematology, 57, 1996, pp. 60-63
Authors:
CLAAS FHJ
Citation: Fhj. Claas, IMMUNE-MECHANISMS LEADING TO DRUG-INDUCED BLOOD DYSCRASIAS, European journal of haematology, 57, 1996, pp. 64-68
Authors:
SCHWARZMEIER JD
Citation: Jd. Schwarzmeier, THE ROLE OF CYTOKINES IN HEMATOPOIESIS, European journal of haematology, 57, 1996, pp. 69-74
Authors:
MARSH JCW
Citation: Jcw. Marsh, LONG-TERM BONE-MARROW CULTURES IN APLASTIC-ANEMIA, European journal of haematology, 57, 1996, pp. 75-79